Accuracy of interferon gamma release assays for the COVID-19 immunity assessment

被引:3
|
作者
Stieber, Francis [1 ]
Allen, Nadia [1 ]
Carpenter, Kara [1 ]
Howard, Jenny [1 ]
Alagna, Riccardo [2 ]
Manissero, Davide [3 ]
Nikolayevskyy, Vladyslav [3 ]
机构
[1] QIAGEN Sci Inc, 19300 Germantown Rd, Germantown, MD 20874 USA
[2] QIAGEN SRL, Via Filippo Sassetti 16, I-20124 Milan, Italy
[3] QIAGEN Manchester, Citylabs 2-0 Hathersage Rd, Manchester M13 0BH, Lancs, England
关键词
SARS-CoV-2; IGRA; T-cell immunity;
D O I
10.1016/j.jviromet.2022.114472
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Emerging evidence suggests that T-cells play a significant role in COVID-19 immunity both in the context of natural infection and vaccination. Easy to use IGRA assays including QFN SARS are considered attractive alternatives to more "traditional" but laborious methods for detection of SARS-CoV-2-specific T-cell responses. In our Letter we are proposing explanations to an apparently lower than expected T-cell responses (44 % reactive individuals) reported by Kruttgen et al in a small cohort of healthy double vaccinated individuals. These results could have been affected by reporting raw optical density values instead of calculated Interferon-gamma concentrations which is supported by unexpectedly low mitogen responses in healthy individuals. This study highlights an importance of adhering to good laboratory practice principles as well as overall importance of accurate T-cell immunity assessment using IGRA assays.
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Nutrition, immunity and COVID-19
    Calder, Philip C.
    BMJ NUTRITION, PREVENTION & HEALTH, 2020, 3 (01) : 74 - 92
  • [42] Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability
    van de Berg, Tom W.
    Hulshof, Anne-Marije M.
    Nagy, Magdolna
    van Oerle, Rene
    Sels, Jan-Willem
    van Bussel, Bas
    ten Cate, Hugo
    Henskens, Yvonne
    Spronk, Henri M. H.
    THROMBOSIS RESEARCH, 2021, 201 : 84 - 89
  • [43] Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays
    Mori, Toru
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2009, 15 (03) : 143 - 155
  • [44] Serological assays for differentiating natural COVID-19 infection from vaccine induced immunity
    Cheng, Samuel M. S.
    Lau, Jonathan J.
    Tsang, Leo C. H.
    Leung, Kathy
    Lee, Cheuk Kwong
    Hachim, Asmaa
    Kavian, Niloufar
    Chaothai, Sara
    Wong, Ricky W. K.
    Yu, Jennifer K. M.
    Chai, Zacary Y. H.
    Mori, Masashi
    Wu, Chao
    Yiu, Karen
    Hui, David S. C.
    Amarasinghe, Gaya K.
    Poon, Leo L. M.
    Wu, Joseph T.
    Valkenburg, Sophie A.
    Peiris, Malik
    JOURNAL OF CLINICAL VIROLOGY, 2024, 170
  • [45] Interleukin 8 but not interferon gamma is predictive of COVID-19 severity: A tunisian study
    Mechi, F.
    Ghozzi, M.
    Melayah, S.
    Taamalia, M.
    Ghedira, I.
    CLINICA CHIMICA ACTA, 2024, 558 : 20 - 20
  • [46] The study of the level of interleukin-6 and gamma interferon in patients with COVID-19
    Davydova, N.
    Putkov, S.
    Kazakov, S.
    CLINICA CHIMICA ACTA, 2024, 558 : 30 - 31
  • [47] 923 Accuracy of Assessment in Hand Trauma; Pre COVID-19 Face to Face Assessment Compared to Virtual Assessment During COVID-19 Lockdown
    Westley, S.
    Creasy, H.
    Mistry, R.
    BRITISH JOURNAL OF SURGERY, 2021, 108 (SUPPL 2)
  • [48] Serology assays to manage COVID-19
    Krammer, Florian
    Simon, Viviana
    SCIENCE, 2020, 368 (6495) : 1060 - 1061
  • [49] On diagnostic accuracy of COVID-19
    Gupta, Harish
    Verma, Sudhir Kumar
    Kumar, Ajay
    Nigam, Nitu
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (09) : 5706 - 5707
  • [50] Interferon gamma release assays and immunosuppressive drugs (including biologic therapy)
    Rivoisy, C.
    Bourgarit, A.
    REVUE DES MALADIES RESPIRATOIRES, 2018, 35 (08) : 887 - 889